Summary
Updated Aug 31, 2026
George K. Ng is Chief Executive Officer, Director of Processa Pharmaceuticals, Inc. (PCSA). 13 SEC Form 4 filings on record going back to 2024, most recently on 11 August 2026. Most recent open-market trade: bought $6K of PCSA on 1 July 2026. Lifetime open-market purchases: $39K. Historical track record: 1/5 stars across 4 tracked purchases.
Recent Transactions
8Every recent SEC Form 4 transaction George K. Ng has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 25% |
| 90-day win rate | 0% |
| Avg 5-day return | -1.87% |
| Avg 30-day return | +0.16% |
| Avg 90-day return | -23.31% |
| Best 30-day return | +6.93% |
Trading Pattern
InsiderAlpha's records for George K. Ng go back to 2024: 13 primary Form 4 filings, an average of 4.3 per year. The typical open-market purchase is $6K (7 buys totaling $39K). The largest single buy on record is $6K of PCSA in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies George K. Ng files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Russell Skibsted - $42K of PCSA open-market activity in the last 12 months
- Wendy Guy - $33K of PCSA open-market activity in the last 12 months
- David Young - $32K of PCSA open-market activity in the last 12 months
- Patrick Lin - $28K of PCSA open-market activity in the last 12 months
- Sian Bigora - $21K of PCSA open-market activity in the last 12 months
- Khoso Baluch - $6K of PCSA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is George K. Ng?
George K. Ng is a corporate insider, tracked as Chief Executive Officer, Director of Processa Pharmaceuticals, Inc. (PCSA). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has George K. Ng submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has George K. Ng been buying or selling stock?
Recorded transactions: 7 open-market purchases ($39K) and 0 open-market sales across all tracked filings.
How accurate is George K. Ng's historical track record?
Across 4 tracked purchases, George K. Ng averaged +0.2% avg 30-day return with a 25% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of George K. Ng's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow George K. Ng and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial